Variability in Alzheimer's disease mortality from European vital statistics, 2012-2020.
Alzheimer's disease
Europe
mortality
trends
Journal
International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
received:
14
11
2023
accepted:
06
02
2024
medline:
2
3
2024
pubmed:
2
3
2024
entrez:
2
3
2024
Statut:
ppublish
Résumé
Data regarding the trends in Alzheimer's disease (AD) mortality in the modern European Union (EU-27) member states are lacking. We assess the sex- and age-specific trends in AD mortality in the EU-27 member states between years 2012 and 2020. Data on cause-specific deaths and population numbers by sex for each country of the EU-27 were retrieved through publicly available European Statistical Office (EUROSTAT) dataset from 2012 to 2020. AD-related deaths were ascertained when the ICD-10 code G30 was listed as the primary cause of death in the medical death certificate. To calculate annual trends, we assessed the average annual percent change (AAPC) with relative 95% confidence intervals (CIs) using Joinpoint regression. During the study period, 751,493 deaths (1.7%, 233,271 males and 518,222 females) occurred in the EU-27 because of AD. Trends in the proportion of AD-related deaths per 1000 total deaths slightly increased from 16.8% to 17.5% (p for trend <0.001). The age-adjusted mortality rate was higher in women over the entire study period. Joinpoint regression analysis revealed a stagnation in age-adjusted AD-related mortality from 2012 to 2020 among EU-27 Member States (AAMR: -0.1% [95% CI: -1.8-1.79], p = 0.94). Stratification by Country showed relevant regional disparities, especially in the Northern and Eastern EU-27 member states. Over the last decade, the age-adjusted AD-related mortality rate has plateaued in EU-27. Important disparities still exist between Western and Eastern European countries.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e6068Informations de copyright
© 2024 John Wiley & Sons Ltd.
Références
Abubakar MB, Sanusi KO, Ugusman A, et al. Alzheimer's disease: an update and insights into pathophysiology. Front Aging Neurosci. 2022;14:742408. https://doi.org/10.3389/fnagi.2022.742408
Karantzoulis S, Galvin JE. Distinguishing Alzheimer's disease from other major forms of dementia. Expert Rev Neurother. 2011;11:1579-1591. https://doi.org/10.1586/ern.11.155
Wolters FJ, Chibnik LB, Waziry R, et al. Twenty-seven-year time trends in dementia incidence in Europe and the United States: the Alzheimer cohorts consortium. Neurology. 2020;95(5):e519-e531. https://doi.org/10.1212/wnl.0000000000010022
Berr C, Wancata J, Ritchie K. Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacol. 2005;15(4):463-471. https://doi.org/10.1016/j.euroneuro.2005.04.003
Wetterberg H, Najar J, Rydén L, et al. Dementia remains the major predictor of death among octogenarians. A study of two population cohorts of 85-year-olds examined 22 years apart. Eur J Epidemiol. 2021;36(5):507-517. https://doi.org/10.1007/s10654-021-00745-5
Meijer E, Casanova M, Kim H, Llena-Nozal A, Lee J. Economic costs of dementia in 11 countries in Europe: estimates from nationally representative cohorts of a panel study. Lancet Reg Health Eur. 2022;20:100445. https://doi.org/10.1016/j.lanepe.2022.100445
GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:88-106.
Nichols E, Steinmetz JD, Vollset SE, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105-e125. https://doi.org/10.1016/s2468-2667(21)00249-8
Liang CS, Li DJ, Yang FC, et al. Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis. Lancet Healthy Longev. 2021;2(8):e479-e488. https://doi.org/10.1016/s2666-7568(21)00140-9
Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST. Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol. 2005;62(5):779-784. https://doi.org/10.1001/archneur.62.5.779
Niu H, Alvarez-Alvarez I, Guillen-Grima F, Al-Rahamneh MJ, Aguinaga-Ontoso I. Trends of mortality from Alzheimer's disease in the European Union, 1994-2013. Eur J Neurol. 2017;24(6):858-866. https://doi.org/10.1111/ene.13302
Accessed January 13, 2024. https://ec.europa.eu/eurostat/databrowser/product/view/hlth_cd_aro
Accessed March 14, 2023. https://ec.europa.eu/eurostat/web/products-manuals-and-guidelines/-/ks-ra-13-028
National Cancer Institute. Number of Joipoints. Accessed March 29, 2023. Retrieved From https://surveillance.cancer.gov/help/joinpoint/setting-parameters/method-and-parameters-tab/number-of-joinpoints
Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ. Comparability of segmented line regression models. Biometrics. 2004;60(4):1005-1014. https://doi.org/10.1111/j.0006-341x.2004.00256.x
Ding C, Wu Y, Chen X, et al. Global, regional, and national burden and attributable risk factors of neurological disorders: the Global Burden of Disease study 1990-2019. Front Public Health. 2022;10:952161. https://doi.org/10.3389/fpubh.2022.952161
Li X, Feng X, Sun X, Hou N, Han F, Liu Y. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019. Front Aging Neurosci. 2022;14:937486. https://doi.org/10.3389/fnagi.2022.937486
Mathers CD. History of global burden of disease assessment at the World Health Organization. Arch Public Health. 2020;78(1):77. https://doi.org/10.1186/s13690-020-00458-3
Li C, He WQ. Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory. Liver Int. 2022;42(10):2299-2316. https://doi.org/10.1111/liv.15357
García-Basteiro AL, Brew J, Williams B, Borgdorff M, Cobelens F. What is the true tuberculosis mortality burden? Differences in estimates by the World Health Organization and the Global Burden of Disease study. Int J Epidemiol. 2018;47(5):1549-1560. https://doi.org/10.1093/ije/dyy144
Dafni U, Tsourti Z, Alatsathianos I. Breast cancer statistics in the European union: incidence and survival across European countries. Breast Care. 2019;14(6):344-353. https://doi.org/10.1159/000503219
Power R, Prado-Cabrero A, Mulcahy R, Howard A, Nolan JM The role of nutrition for the aging population: implications for cognition and Alzheimer's disease. Annu Rev Food Sci Technol 2019;10(1):619-639. https://doi.org/10.1146/annurev-food-030216-030125
Sabbagh MN, Lue LF, Fayard D, Shi J. Increasing precision of clinical diagnosis of alzheimer's disease using a combined algorithm incorporating clinical and novel biomarker data. Neurol Ther. 2017;6(S1):83-95. https://doi.org/10.1007/s40120-017-0069-5
Niu H, Álvarez-Álvarez I, Guillén-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis. Neurologia. 2017;32(8):523-532. https://doi.org/10.1016/j.nrleng.2016.02.009
Mielke MM. Sex and gender differences in alzheimer's disease dementia. Psychiatr Times. 2018;35:14-17.
Subramaniapillai S, Almey A, Natasha Rajah M, Einstein G. Sex and gender differences in cognitive and brain reserve: implications for Alzheimer's disease in women. Front Neuroendocrinol. 2021;60:100879. https://doi.org/10.1016/j.yfrne.2020.100879
Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol. 2021;153(2):132-136. https://doi.org/10.1093/aje/153.2.132
Eiser AR. Why does Finland have the highest dementia mortality rate? Environmental factors may be generali. Brain Res. 2017;1671:14-17. PMID: 16622828; PMCID: PMC3024594zable. https://doi.org/10.1016/j.brainres.2017.06.032
Scarmeas N, Stern Y, TangMayeuxLuchsinger MXRJA, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol. 2006;59(6):912-921. https://doi.org/10.1002/ana.20854
Shannon OM, Ranson JM, Gregory S, et al. Mediterranean diet adherence is associated with lower dementia risk, independent of genetic predisposition: findings from the UK Biobank prospective cohort study. BMC Med. 2023;21(1):81. https://doi.org/10.1186/s12916-023-02772-3
Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol. 2006;59(6):912-921. https://doi.org/10.1002/ana.20854
Ward A, Crean S, Mercaldi CJ, et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis. Neuroepidemiology. 2012;38:1-17. https://doi.org/10.1159/000334607
Tóth P, Gavurová B, Barták M. Alzheimer's disease mortality according to socioeconomic factors: country study. Int J Alzheimer's Dis. 2018;2018:8137464. https://doi.org/10.1155/2018/8137464
Zuin M, Roncon L, Passaro A, Cervellati C, Zuliani G. Metabolic syndrome and the risk of late onset Alzheimer's disease: an updated review and meta-analysis. Nutr Metab Cardiovasc Dis. 2021;31(8):2244-2252. https://doi.org/10.1016/j.numecd.2021.03.020
Golzari-Sorkheh M, Weaver DF, Reed MA. COVID-19 as a risk factor for alzheimer's disease. J Alzheimers Dis. 2023;91:1-23. https://doi.org/10.3233/jad-220800
Wang L, Davis PB, Volkow ND, Berger NA, Kaelber DC, Xu R. Association of COVID-19 with new-onset alzheimer's disease. J Alzheimers Dis. 2022;89(2):411-414. https://doi.org/10.3233/jad-220717
Muhrer JC. Risk of misdiagnosis and delayed diagnosis with COVID-19: a Syndemic Approach. Nurse Pract. 2021;46(2):44-49. https://doi.org/10.1097/01.npr.0000731572.91985.98
Greco A, Cascavilla L, Paris F, et al. Undercoding of Alzheimer's disease and related dementias in hospitalized elderly patients in Italy. Am J Alzheimers Dis Other Demen. 2005;20(3):167-170. https://doi.org/10.1177/153331750502000307
Kautzky A, Seiger R, Hahn A, et al. Prediction of autopsy verified neuropathological change of alzheimer's disease using machine learning and MRI. Front Aging Neurosci. 2018;10:406. https://doi.org/10.3389/fnagi.2018.00406
Ostbye T, Hill G, Steenhuis R. Mortality in elderly Canadians with and without dementia: a 5-year follow-up. Neurology. 1999;53(3):521-526. https://doi.org/10.1212/wnl.53.3.521
Solomon A, Ngandu T, Soininen H, Hallikainen MM, Kivipelto M, Laatikainen T. Validity of dementia and Alzheimer's disease diagnoses in Finnish national registers. Alzheimers Dement. 2014;10(3):303-309. https://doi.org/10.1016/j.jalz.2013.03.004
Kim M, Sekiya H, Yao G, et al. Diagnosis of alzheimer disease and tauopathies on whole-slide histopathology images using a weakly supervised deep learning algorithm. Lab Invest. 2023;103(6):100127. https://doi.org/10.1016/j.labinv.2023.100127
Wilkinson T, Ly A, Schnier C, et al. Identifying dementia cases with routinely collected health data: a systematic review. Alzheimers Dement. 2018;14(8):1038-1051. https://doi.org/10.1016/j.jalz.2018.02.016